Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2051250119) titled 'ONO-4578-10:A study to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo(R), in combination with mFOLFOX6 and bevacizumab versus standard of care in participants with non-MSI-H/dMMR, PD-L1 positive advanced colorectal cancer' on Sept. 29.
Study Type: Interventional
Study Design:
randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose
Primary Sponsor: Hirashima Yoshinori
Condition:
Advanced colorectal cancer
Intervention:
ONO-4578, nivolumab, chemotherapy (oxaliplatin, fluorouracil, and levofolinate calcium hydrate [mFOLFOX6 r...